Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.66 |
| ▸ | GAA | P10253 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | PTPRA | P18433 | 1/20 | 0.65 |
| ▸ | PTPRB | P23467 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | MPL | P40238 | 2/20 | 0.60 |
| ▸ | CTRC | Q99895 | 2/20 | 0.60 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.59 |
| ▸ | ATIC | P31939 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11877650 | 1.00 | MAPT (0.66) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL11336943 | 0.88 | MAPT (0.80) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL109165 | 0.88 | MAPT (0.80) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL29376978 | 0.88 | MAPT (0.80) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL92162 | 0.88 | MAPT (0.80) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL4412992 | 0.88 | MAPT (0.80) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL144505 | 0.87 | MAPT (0.78) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL30842302 | 0.87 | MAPT (0.78) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL144503 | 0.87 | MAPT (0.78) | MAPTKMT2ATDP1MAPK1GAA | |
| SCHEMBL14025123 | 0.86 | CD40 (0.71) | KMT2ATDP1MAPK1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115489-A1 | NOVEL MEDIATOR | KIKKOMAN CORPORATION (JP) | 2021-04-22 | — | — | US | disclosed |
| US-3966900-A | INSECTICIDES | AIRWICK INDUSTRIES, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115489-A1 | NOVEL MEDIATOR | MPO, EPX, LPO | MAPT 4015/4885KMT2A 3104/4885TDP1 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.